Emily J Gallagher Selected Research

Emily J Gallagher Research Topics

Disease

33	Neoplasms (Cancer) 09/2023 - 09/2010
13	Obesity 02/2022 - 09/2010
13	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2013
10	Insulin Resistance 10/2021 - 09/2010
10	Hyperinsulinism (Hyperinsulinemia) 01/2019 - 07/2011
9	Hyperglycemia 01/2024 - 09/2010
8	Type 2 Diabetes Mellitus (MODY) 10/2021 - 07/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2013
3	Body Weight (Weight, Body) 01/2024 - 12/2015
3	Triple Negative Breast Neoplasms 01/2021 - 10/2014
3	Dyslipidemias (Dyslipidemia) 11/2018 - 01/2013
3	Carcinogenesis 04/2018 - 09/2010
2	Lung Neoplasms (Lung Cancer) 11/2021 - 02/2015
2	Diabetes Mellitus 10/2021 - 09/2010
2	Hypercholesterolemia 01/2021 - 12/2015
2	Fatigue 07/2020 - 12/2019
2	Hypophysitis 07/2020 - 12/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 09/2010
1	Exanthema (Rash) 01/2024
1	Breast Cancer Lymphedema 01/2024
1	Lymphedema (Milroy Disease) 01/2024
1	Weight Gain 01/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Gastro-enteropancreatic neuroendocrine tumor 10/2021
1	COVID-19 02/2021
1	Chronic Renal Insufficiency 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 12/2020
1	Chronic Disease (Chronic Diseases) 12/2020
1	Hypopituitarism (Sheehan's Syndrome) 07/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2019
1	Thyroiditis 12/2019
1	Primary Myelofibrosis (Myelosclerosis) 11/2019
1	Polycythemia Vera 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 09/2023 - 09/2010
9	Immune Checkpoint InhibitorsIBA 07/2023 - 10/2017
8	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 09/2010
8	Insulin ReceptorIBA 12/2020 - 09/2010
4	Blood Glucose (Blood Sugar)IBA 02/2022 - 12/2015
4	AdipokinesIBA 11/2018 - 09/2010
4	CytokinesIBA 11/2018 - 09/2010
3	Insulin-Like PeptidesIBA 01/2022 - 10/2013
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 10/2013
3	Hormones (Hormone)IBA 10/2021 - 12/2015
3	Estrogens (Estrogen)FDA Link 12/2020 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2013
2	Estrogen ReceptorsIBA 09/2022 - 12/2020
2	LDL CholesterolIBA 01/2021 - 01/2018
2	Estradiol (Delestrogen)FDA LinkGeneric 12/2020 - 12/2015
2	Somatomedin Receptors (Somatomedin Receptor)IBA 12/2020 - 12/2013
2	Monoclonal AntibodiesIBA 12/2019 - 10/2017
2	NivolumabIBA 12/2019 - 10/2017
2	Insulin Glargine (Lantus)FDA Link 01/2017 - 01/2016
2	LipidsIBA 10/2016 - 12/2015
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2014 - 07/2011
2	Nonesterified Fatty Acids (NEFA)IBA 01/2014 - 09/2010
2	Insulin-Like Growth Factor I (IGF-1)IBA 12/2013 - 07/2011
1	AlpelisibIBA 01/2024
1	Histamine Antagonists (Antihistamines)IBA 01/2024
1	SteroidsIBA 01/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	MineralsIBA 02/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 11/2021
1	Glucose Transporter Type 4IBA 10/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2021
1	GlucocorticoidsIBA 02/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	CholesterolIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	AutoantibodiesIBA 07/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2020
1	AntibodiesIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 07/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 12/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2019
1	IpilimumabIBA 12/2019
1	Anterior Pituitary HormonesIBA 12/2019
1	ruxolitinibIBA 11/2019
1	Janus KinasesIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	ChromatinIBA 01/2019
1	Histones (Histone)IBA 01/2019

Therapy/Procedure

9	Therapeutics 02/2023 - 09/2010
1	Injections 09/2023
1	Glycemic Control 02/2022
1	Castration 01/2022
1	Drug Therapy (Chemotherapy) 10/2021
1	Hysterectomy 12/2020
1	Caloric Restriction 01/2019